GlaxoSmithKline plc - Continuation of Share Buy-Back Programme during close period
GlaxoSmithKline plc (the "Company") announces that it has today put in place an irrevocable, non-discretionary programme for the purchase of its Ordinary shares during the close period which precedes the 2013 second quarter results announcement, expected to be made on 24 July 2013. The shares to be purchased on behalf of the Company will either be cancelled or held in treasury.
The aim of the programme is to reduce the issued share capital of the Company to help enhance returns for shareholders.
The repurchases, to be made under the Company's existing share buy-back programme, will be managed during the close period by an independent third party which makes its trading decisions in relation to the Company's securities independently of, and uninfluenced by, the Company.
Any purchases pursuant to these arrangements will be carried out during the period between 1 July 2013 and 23 July 2013 within certain pre-set parameters and in accordance with the Listing Rules, other applicable law and the limitations of the repurchase authority approved at the last Annual General Meeting of shareholders.
V A Whyte
Company Secretary
28 June 2013
